|
|
| | Adipose Triglyceride Lipase Blocking Peptide Basic information |
| | Adipose Triglyceride Lipase Blocking Peptide Chemical Properties |
| | Adipose Triglyceride Lipase Blocking Peptide Usage And Synthesis |
| Description | To be used in conjunction with Cayman’s Adipose Triglyceride Lipase polyclonal antibody (Catalog No. 10006409) to block protein-antibody complex formation during immunochemical analysis of adipose triglyceride lipase protein. · Triglycerides are the most efficient form of energy storage in mammalian adipose tissue during times of caloric excess. ATGL is one of the key enzymes involved in the mobilization of fatty acids from triglyceride stores in adipose tissue, catalyzing the conversion of triacylglycerols to diacylglycerols. Inhibition of ATGL markedly decreases total adipose acyl-hydrolase activity, and thus may be a potential drug target for the diabetic pathology. ATGL mRNA is detected in a wide range of tissues including adipose, lung, skeletal muscle, testis, heart, brain, and kidney, with adipose tissue expressing the highest level. Human ATGL is 504 amino acids in length with an estimated molecular weight of 55.2 kDa. Cayman’s ATGL polyclonal antibody detects the enzyme at 56 kDa by western blot from tissues and cells such as brown fat, liver, murine macrophages, and HepG2 cells. |
| | Adipose Triglyceride Lipase Blocking Peptide Preparation Products And Raw materials |
|